A widening perspective regarding the relationship between anti-epiligrin cicatricial pemphigoid and cancer
- PMID: 17467241
- DOI: 10.1016/j.jdermsci.2007.02.012
A widening perspective regarding the relationship between anti-epiligrin cicatricial pemphigoid and cancer
Abstract
Anti-epiligrin cicatricial pemphigoid (AECP) is a chronic, autoimmune, subepidermal blistering disease characterized by circulating anti-basement membrane autoantibodies to laminin 5. Recent studies have shown that patients with this form of cicatricial pemphigoid have an increased relative risk for malignant solid tumors. The mechanism underlying this association of AECP and cancer is unknown, but there is accumulating evidence that laminin 5 plays a central role. In this article we report a patient with AECP and co-associated cutaneous T cell lymphoma and summarize all to date reported cases of AECP associated with malignancies. In addition we provide a review of the biology of laminin 5 and its potential role in cancer development.
Similar articles
-
Anti-epiligrin cicatricial pemphigoid: clinical findings, immunopathogenesis, and significant associations.Medicine (Baltimore). 2003 May;82(3):177-86. doi: 10.1097/01.md.0000076003.64510.00. Medicine (Baltimore). 2003. PMID: 12792304
-
Two cases of anti-epiligrin cicatricial pemphigoid with and without associated malignancy.Acta Derm Venereol. 2008;88(5):484-7. doi: 10.2340/00015555-0506. Acta Derm Venereol. 2008. PMID: 18779887
-
Relative risk for cancer in mucous membrane pemphigoid associated with antibodies to the beta4 integrin subunit.Clin Exp Dermatol. 2007 Nov;32(6):637-41. doi: 10.1111/j.1365-2230.2007.02463.x. Epub 2007 May 25. Clin Exp Dermatol. 2007. PMID: 17524068
-
The clinical and immunopathological manifestations of anti-epiligrin cicatricial pemphigoid, a recently defined subepithelial autoimmune blistering disease.Eur J Dermatol. 2000 Dec;10(8):585-9. Eur J Dermatol. 2000. PMID: 11125317 Review.
-
Studies of patients with anti-epiligrin cicatricial pemphigoid.J Dermatol. 1995 Nov;22(11):829-35. doi: 10.1111/j.1346-8138.1995.tb03931.x. J Dermatol. 1995. PMID: 8557854 Review.
Cited by
-
Severe Refractory Paraneoplastic Mucous Membrane Pemphigoid Successfully Treated With Rituximab.Front Med (Lausanne). 2019 Jan 29;6:8. doi: 10.3389/fmed.2019.00008. eCollection 2019. Front Med (Lausanne). 2019. PMID: 30761304 Free PMC article.
-
IgG anti-laminin-332 autoantibodies are present in a subset of patients with mucous membrane, but not bullous, pemphigoid.J Am Acad Dermatol. 2008 Jun;58(6):951-8. doi: 10.1016/j.jaad.2008.02.035. Epub 2008 Apr 8. J Am Acad Dermatol. 2008. PMID: 18396347 Free PMC article.
-
Mucous Membrane Pemphigoid-Associated Malignancies: Case Series and a Brief Overview of the Literature.Dermatol Pract Concept. 2019 Apr 30;9(2):119-125. doi: 10.5826/dpc.0902a07. eCollection 2019 Apr. Dermatol Pract Concept. 2019. PMID: 31106014 Free PMC article.
-
Case Report: The many faces of bullous pemphigoid.Front Immunol. 2023 Oct 12;14:1272742. doi: 10.3389/fimmu.2023.1272742. eCollection 2023. Front Immunol. 2023. PMID: 37901243 Free PMC article.
-
A Probing of the Issue of Detecting IgG, IgG4 and IgA Antibodies to Laminin 332 Epitopes in Mucous Membrane Pemphigoid: A Clinical-Laboratory Experience of a Single Central European University Dermatology Department.Clin Cosmet Investig Dermatol. 2022 Apr 27;15:783-790. doi: 10.2147/CCID.S359589. eCollection 2022. Clin Cosmet Investig Dermatol. 2022. PMID: 35510222 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical